Function Health Prescription and Intake Process: A Critical Review

What Is Function Health and How Does the Intake Process Work?

Function Health positions itself as a lab-first telehealth company. Members pay an annual subscription, get a blood draw requisition sent to a local Quest Diagnostics site, and receive a structured dashboard report with provider commentary. The intake sequence runs roughly four steps: sign up and complete a health history questionnaire, schedule a draw at a Quest location, review results with a dashboard explainer, and book a follow-up consultation if prescriptions or further workup are warranted.

The health history questionnaire covers current medications, family history, chronic diagnoses, and symptom burden. This information feeds a licensed clinician's review of the lab results. The questionnaire is not diagnostic on its own; it contextualizes the numbers. If the clinician identifies a treatable abnormality, say, overt hypothyroidism confirmed by a TSH above the American Thyroid Association's reference range, a prescription can be issued through the platform without a separate in-person visit.

The Blood Draw Step

Function Health uses Quest Diagnostics, which operates more than 2,200 patient service centers in the United States and holds CLIA certification required under 42 CFR Part 493. Members receive a requisition code, visit any participating Quest site as a walk-in or scheduled appointment, and the sample ships to Quest's central processing labs. There is no additional out-of-pocket cost for the draw itself under the $499 membership.

Dashboard and Clinician Review

Results populate a proprietary dashboard that color-codes values as optimal, borderline, or abnormal relative to reference ranges. Each biomarker includes a plain-language explainer. A licensed physician or nurse practitioner reviews every panel before it is released to the member. This is not automated-only reporting; a clinician signs off. The review cycle adds one to three days to result turnaround.

Triggering a Prescription

Not every abnormal value results in a prescription. The clinician may recommend lifestyle changes, repeat testing, or referral to a specialist. Prescriptions are issued when lab findings meet recognized clinical thresholds, for example, a free testosterone below 300 ng/dL in a symptomatic male meeting the Endocrine Society's diagnostic criteria for hypogonadism, or a TSH above 10 mIU/L meeting American Thyroid Association criteria for overt hypothyroidism. The prescription is transmitted electronically to a pharmacy of the member's choice, not fulfilled by Function Health directly.

What Does Function Health Actually Prescribe?

Function Health does not operate a pharmacy and does not limit prescriptions to a proprietary formulary. Prescriptions written through the platform follow standard clinical pathways.

Thyroid Medications

Hypothyroidism affects approximately 4.6% of the U.S. Population aged 12 and older, per a National Health and Nutrition Examination Survey analysis published in JAMA Internal Medicine ([1]). Function Health's panel includes TSH, free T4, and free T3. When results indicate overt hypothyroidism, levothyroxine is the first-line treatment per American Thyroid Association 2014 guidelines, which state: "Levothyroxine (LT4) is the recommended thyroid hormone for the treatment of hypothyroidism" ([2]). Subclinical hypothyroidism (TSH 4.5 to 10 mIU/L) is handled case by case; not every subclinical case warrants medication, and Function Health clinicians follow that same discretion.

Testosterone Replacement Therapy

The platform tests total testosterone, free testosterone, SHBG, LH, and FSH. Male hypogonadism diagnosis requires both biochemical evidence and symptoms. The Endocrine Society's 2018 clinical practice guideline defines the threshold as "a total testosterone concentration below 300 ng/dL on at least two morning measurements" combined with signs and symptoms ([3]). Function Health can initiate testosterone cypionate injections, topical gels, or other FDA-approved TRT formulations when criteria are met.

For women, DHEA-S, estradiol, and progesterone are included. Menopausal hormone therapy decisions follow North American Menopause Society guidance.

Metabolic and Cardiometabolic Medications

The panel includes fasting glucose, insulin, HbA1c, and a full lipid fractionation. If HbA1c meets the American Diabetes Association's 2024 diagnostic cut-off of 6.5% or greater on two separate tests, a clinician can prescribe metformin as first-line therapy consistent with ADA Standards of Care ([4]). For dyslipidemia, statin prescriptions align with ACC/AHA 2019 guidelines on atherosclerotic cardiovascular disease risk ([5]).

GLP-1 receptor agonists such as semaglutide or tirzepatide are available for qualifying members with a BMI of 30 or greater, or a BMI of 27 or greater with an obesity-related comorbidity. This meets the FDA-approved indication criteria.

Other Prescriptions

Vitamin D deficiency confirmed by a 25-OH vitamin D below 20 ng/mL (per the Endocrine Society's clinical practice guideline) may prompt a prescription-strength ergocalciferol or cholecalciferol dose ([6]). Iron deficiency anemia, B12 deficiency, and certain hormonal imbalances identified by the panel can also result in prescriptions when clinically appropriate.

Is Function Health Legit? Evaluating the Evidence Base

Legitimacy has two layers: regulatory compliance and clinical validity.

Regulatory Standing

Function Health operates as a telehealth platform subject to state medical practice acts and federal telehealth regulations. Its clinicians hold state licensure in the states where they practice. Labs are processed through Quest Diagnostics' CLIA-certified facilities. CLIA certification is a federal quality standard administered by CMS under 42 CFR Part 493, covering proficiency testing, quality control, and personnel standards ([7]).

The platform is not a direct-to-consumer lab that bypasses physician oversight. Every result is reviewed by a licensed provider before release, which distinguishes it from pure self-pay lab-ordering services that issue results without clinical interpretation.

Clinical Validity of the Biomarker Panel

Many of the 100-plus markers on the panel are supported by strong evidence. HbA1c, LDL-C, TSH, creatinine, and hsCRP have decades of randomized and prospective cohort data linking their values to clinical outcomes. The Framingham Heart Study, for example, provided foundational evidence linking lipid fractions to cardiovascular event risk, data that now underpins ACC/AHA guideline thresholds ([5]).

Some markers in a "longevity" panel require more nuance. IGF-1, for instance, appears on many longevity panels as a proxy for growth hormone status. Its relationship to all-cause mortality shows a J-shaped curve in large observational studies, meaning both very low and very high values associate with increased risk, but a single measurement in an asymptomatic person has limited actionable precision without clinical context ([8]).

The Endocrine Society notes in its 2019 position statement that routine screening for growth hormone deficiency in adults without specific clinical indicators is not recommended. Function Health's clinicians are positioned to make that distinction, but members should understand that not every biomarker on the panel has the same weight of actionable evidence behind it.

The "Optimal Range" Framing

Function Health presents some results against "optimal" ranges rather than only standard laboratory reference ranges. This is a meaningful difference. Reference ranges reflect the middle 95% of a healthy population. "Optimal" targets are often based on observational data suggesting better outcomes at tighter ranges. For LDL-C, the ACC/AHA 2019 guideline does set explicit risk-stratified targets (LDL-C below 70 mg/dL for very-high-risk patients), lending evidence support to tighter targets in certain individuals ([5]). For other markers, the "optimal" designation relies on weaker observational evidence or expert opinion. Patients should ask their Function Health clinician to distinguish between these evidence grades for any biomarker driving a clinical decision.

How Much Does Function Health Cost?

The base membership is $499 per year. This covers two annual blood draws and the associated lab fees with Quest Diagnostics, plus dashboard access and clinician review of each panel.

Prescriptions are billed separately at standard pharmacy prices. Function Health does not accept insurance for the membership fee, but the subscription is eligible for payment through HSA and FSA accounts, which can reduce after-tax cost for members in higher tax brackets.

For comparison, ordering a comparable panel a la carte through Quest Diagnostics' self-pay portal (QuestDirect) would cost several hundred to over a thousand dollars depending on which tests are selected. A 2023 price audit by a consumer health publication estimated that replicating roughly 80 of the 100-plus markers Function Health includes would run $800 to $1,400 at retail self-pay prices without membership discounts.

Add-on tests beyond the standard panel and any specialist consultations are priced separately.

Function Health vs. Alternatives

Several platforms compete in the lab-driven telehealth space. The comparison points that matter most are panel breadth, clinical oversight quality, prescription capability, and cost.

Function Health vs. Lifeforce

Lifeforce targets a similar longevity-oriented consumer and charges approximately $549 for an initial diagnostic, then $299 per quarter for follow-up panels. Its panel is narrower than Function Health's, focusing primarily on hormones and metabolic markers. Lifeforce includes one-on-one clinician coaching, which Function Health does not offer in its standard tier. Prescription access is available through both platforms.

Function Health vs. Inside Tracker

InsideTracker focuses on biomarker tracking for athletic performance optimization. Its top-tier Ultimate Plan runs approximately $699 for a single blood test with algorithm-driven recommendations. InsideTracker does not prescribe medications; it issues lifestyle and supplement recommendations. For members seeking prescription access, Function Health has a clear structural advantage.

Function Health vs. Direct Primary Care (DPC) Practices

A Direct Primary Care practice typically charges $75 to $150 per month, which includes unlimited primary care visits, often with in-house lab discounts. A DPC physician can order comparable panels, interpret results, and prescribe. For members who want a longitudinal clinical relationship and are not driven by the specific 100-plus marker panel, DPC may offer better overall value. The American Academy of Family Physicians maintains a directory of DPC practices ([9]).

Function Health vs. Traditional Insurance-Based Care

Under standard insurance-based care, comprehensive metabolic panels, lipid panels, TSH, and CBC are covered at no cost when ordered by a physician for a covered indication. The challenge is that preventive "longevity" panels, including IGF-1, omega-3 index, and advanced lipid fractionation, are frequently not covered because they lack an ICD-10 diagnosis code that insurers recognize. Function Health's flat-fee model removes that barrier but shifts the entire cost to the member.

The table below summarizes the key comparison points across platforms.

| Platform | Annual Cost | Panel Size | Rx Capable | Clinician Access | |---|---|---|---|---| | Function Health | $499 | 100+ markers | Yes | Async review + consult | | Lifeforce | ~$1,400 | 40-50 markers | Yes | Coaching included | | InsideTracker Ultimate | ~$699/draw | 40 markers | No | Algorithm only | | DPC Practice | $900-$1,800 | Variable | Yes | Ongoing relationship | | Insurance-based PCP | Variable copays | Coverage-limited | Yes | Variable access |

Lab-Driven Longevity: What the Evidence Actually Supports

The "longevity medicine" framing Function Health uses reflects a genuine and expanding area of clinical research, but it sits at different evidence levels depending on the specific intervention.

Strong Evidence Tier

Cardiovascular risk reduction through LDL-C lowering is among the most replicated findings in medicine. The Cholesterol Treatment Trialists' 2010 meta-analysis of 26 statin trials (N=169,138) found that each 1 mmol/L reduction in LDL-C reduced major vascular events by approximately 21% (P<0.0001) ([10]). Early identification and treatment through a platform like Function Health can meaningfully reduce risk in people who would otherwise go undiagnosed between infrequent primary care visits.

Glycemic control data are similarly strong. The UK Prospective Diabetes Study (UKPDS 33, N=3,867) showed that intensive blood glucose control with metformin reduced diabetes-related endpoints by 32% compared with conventional management in overweight patients ([11]).

Emerging Evidence Tier

Telomere length, biological age clocks (such as DNA methylation clocks), and proteomics-based aging scores are included or adjacent to what platforms like Function Health discuss. These markers associate with longevity in observational data but have not yet been validated as modifiable targets in randomized trials. The National Institute on Aging has funded research in this area, but no clinical guideline body currently recommends routine biological age testing in asymptomatic adults ([12]).

The Gap Between Testing and Outcomes

Detecting an abnormality is not the same as preventing a disease event. The U.S. Preventive Services Task Force (USPSTF) applies a rigorous benefit-harm framework to screening recommendations. Many of the biomarkers in Function Health's extended panel have not been evaluated by the USPSTF as population screening tools because the evidence chain from early detection to improved clinical outcomes has not been fully established in prospective trials ([13]).

This is not an argument against testing. It is an argument for calibrated expectations. Members who enter Function Health's platform expecting that a 100-biomarker panel will definitively predict or prevent all-cause mortality are relying on science that does not yet exist. Members who use it to catch treatable metabolic and hormonal abnormalities early are on far firmer ground.

Function Health Reviews: What Members and Clinicians Report

Published peer-reviewed studies on Function Health as a platform do not exist; the company is private and has not published outcomes data. Available reviews are consumer-generated on platforms such as Trustpilot and Google, where the service averages approximately 4.5 out of 5 stars based on several hundred reviews as of mid-2025. Common praise focuses on the breadth of testing and the clarity of the dashboard. Common criticisms include the lack of real-time clinician access in the standard tier and the cost of prescriptions and add-ons beyond the base membership.

Clinician perspectives divide along predictable lines. Physicians who practice preventive medicine and functional medicine tend to view comprehensive baseline panels as worthwhile for motivated patients. Physicians focused on value-based care question whether the incremental information from markers beyond standard preventive panels changes management often enough to justify the cost in asymptomatic individuals.

The American College of Preventive Medicine's framework for preventive screenings emphasizes that a test is only as valuable as the clinical action it enables and the patient's capacity to act on results ([14]). Function Health's prescription capability closes part of that gap compared with platforms that report results without follow-through.